Bicipital tendonitis is inflammation of long head of the biceps tendon under the bicipital groove.
In early stage, tendon becomes red and swollen, as tendonitis develops the tendon sheath can thicken.
In late stage, often become dark red in color due to inflammation.
THE URINARY INCONTINENCE AND IT'S MANAGEMENT DETAILS WITH APPROPRIATE EXPLANATION
Introduction of urinary incontinence,
Etiology of urinary incontinence,
Risk factors associated with urinary incontinence,
Types of urinary incontinence,
Pathophysiology of Urinary incontinence,
Clinical manifestations of urinary incontinence,
Diagnostic evaluations of urinary incontinence,
Management of urinary incontinence- Behavioural techniques, Drug therapy, surgical management, medical devices and Physiotherapy assessment and management in details with appropriate explanation with the help of the SlideShare .
Telegram channel - https://t.me/bhuneshwarmishra08/4?single
Facebook page - https://m.facebook.com/Bhuneshwarmishra08/
Instagram page - https://www.instagram.com/the_perfect_physio_tutorial/?r=nametag
YouTube channel - https://youtube.com/channel/UCCIEa_xDe3B-6BLfQaJb8PQ
Educational resource from ReLiva Physiotherapy, for patients suffering from frozen shoulder or adhesive capsulitis. Has details on stages of frozen shoulder, home remedy tips and physiotherapy treatment and exercises. Not a medical advice.
Bicipital tendonitis is inflammation of long head of the biceps tendon under the bicipital groove.
In early stage, tendon becomes red and swollen, as tendonitis develops the tendon sheath can thicken.
In late stage, often become dark red in color due to inflammation.
THE URINARY INCONTINENCE AND IT'S MANAGEMENT DETAILS WITH APPROPRIATE EXPLANATION
Introduction of urinary incontinence,
Etiology of urinary incontinence,
Risk factors associated with urinary incontinence,
Types of urinary incontinence,
Pathophysiology of Urinary incontinence,
Clinical manifestations of urinary incontinence,
Diagnostic evaluations of urinary incontinence,
Management of urinary incontinence- Behavioural techniques, Drug therapy, surgical management, medical devices and Physiotherapy assessment and management in details with appropriate explanation with the help of the SlideShare .
Telegram channel - https://t.me/bhuneshwarmishra08/4?single
Facebook page - https://m.facebook.com/Bhuneshwarmishra08/
Instagram page - https://www.instagram.com/the_perfect_physio_tutorial/?r=nametag
YouTube channel - https://youtube.com/channel/UCCIEa_xDe3B-6BLfQaJb8PQ
Educational resource from ReLiva Physiotherapy, for patients suffering from frozen shoulder or adhesive capsulitis. Has details on stages of frozen shoulder, home remedy tips and physiotherapy treatment and exercises. Not a medical advice.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
2. WHAT IS PID?
• PID, also known as Pelvic Inflammatory Disease is a disease of
the upper genital tract.
• It is a spectrum of infection and inflammation of the upper
genital tract organs typically involving the uterus
(endometrium), fallopian tubes, ovaries, pelvic peritoneum and
surrounding structures.
• C. trachomatis is the commonest cause, and N. gonorrhoeae
and Mycoplasma hominis are frequent causes.
• Such infections may occur independently or concurrently, and
are sexually transmitted.
• The infection causes inflammation, and the body’s response in
the highly vascular pelvic area is the production of adhesions
(sometimes profuse) and scarring, which contort structures and
glue or bind them to adjacent ones.
• Chronic PID does not run a predictable course. Some cases even
resolve spontaneously. A broad-spectrum antibiotic is often
given and surgery to remove the uterus, ovaries and fallopian
tubes is often advocated
3. • Chlamydia trachomatis is an important cause
of pelvic inflammatory disease.
• Gelatinous exudates are formed in the pouch
of Douglas, proceeding to multiple adhesions and
tubal occlusion.
• It does not, however, produce a noticeable
discharge.
• Vaginal organisms are transmitted sexually so,
in treatment, partners must also be considered.
• Severe cases may present with cervicitis that
looks like an infected erosion.
• It has also been suggested that Chlamydia may
be an etiological factor in cervical carcinoma.
4.
5. • Neisseria gonorrhoeae is the causative
organism of gonorrhoea.
• This may be asymptomatic or with a
light discharge and can cause pelvic
inflammatory disease.
• It can further affect the urethra, cervix,
rectum and mouth. Transmission to a
fetus at birth can cause neonatal
conjunctivitis, which, if it remains
untreated, can cause blindness.
• It is a notifiable disease and is treated
with penicillin; sexual partners should
always be traced to be tested and treated
if necessary.
8. Protective Factors
Contraceptive practice
• Barrier methods, especially condoms, diaphragm with
spermicides
• Oral steroidal contraceptives have got two preventive
aspects.
1.Produce thick mucus plug preventing ascent of sperm
and bacterial penetration
2. A decrease in duration of menstruation creates a shorter
interval of bacterial colonization of the upper tract.
• Monogamy or having a partner who had a vasectomy.
Others
• Pregnancy
• Menopause
• Vaccines: hepatitis B, HPV
9. Mode of
Affection
• The classic concept is that the gonococcus
ascends up to affect the tubes through
mucosal continuity and contiguity. This
ascent is facilitated by the sexually
transmitted vectors such as sperm and
trichomonads.
• Reflux of menstrual blood and gonococci
into the fallopian tubes is the other possibility.
• Mycoplasma hominis probably spreads
across the parametrium to affect the tube.
• The secondary organisms probably affect the
tube through lymphatics.
• Rarely, organisms from the gut may affect
the tube directly.
10. Pathology
• The involvement of the tube is almost always bilateral and
usually following menses due to loss of genital defense.
• The pathological process is initiated primarily in the endo
salpinx.
• There is gross destruction of the epithelial cells, cilia, and
microvilli. In severe infection, it invades all the layers of the
tube and produces an acute inflammatory reaction; it
becomes edematous and hyperemic.
• The exfoliated cells and the exudate pour into the lumen of
the tube and agglutinate the mucosal folds. The abdominal
ostium is closed by the indrawing of the edematous fimbriae
and by inflammatory adhesions.
11. • The uterine end is closed by congestion. The closure of both the ostia results in pent
up of the exudate inside the tube. Depending upon the virulence, the exudate may be
watery, producing hydrosalpinx or purulent, producing pyosalpinx.
• The purulent exudate then changes the microenvironment of the tube which favors
growth of other pyogenic and anaerobic organisms resulting in deeper penetration
and more tissue destruction. The organisms spontaneously die within 2–3 weeks. As
the serous coat is not much affected, the resulting adhesions of the tube with the
surrounding structures are not so dense, in fact flimsy, unlike pyogenic or tubercular
infection.
• On occasions, the exudate pours through the abdominal ostium to produce pelvic
peritonitis and pelvic abscess or may affect the ovary (the organisms gain access
through the ovulation rent) producing ovarian abscess. A tubo-ovarian abscess is thus
formed.
12.
13. Clinical Features
• Symptoms usually appear at the time
and immediately after the menstruation.
• Bilateral lower abdominal and pelvic
pain which is dull in nature.
• The onset of pain is more rapid and
acute in gonococcal infection (3 days)
than in chlamydial infection (5–7 days).
• There is fever, lassitude and headache.
• Irregular and excessive vaginal
bleeding is usually due to associated
endometritis.
• Abnormal vaginal discharge which
becomes purulent and or copious.
14. • Nausea and vomiting.
• Dyspareunia.
• Pain and discomfort in the right hypochondrium due to concomitant
perihepatitis (Fitz-Hugh-Curtis syndrome) may occur in 5–10 per cent of
cases of acute salpingitis.
• The liver is involved due to transperitoneal or vascular dissemination of
gonococcal or chlamydial infection.
15.
16. • The temperature is elevated to beyond 38.3°C.
• Abdominal palpation reveals tenderness on both quadrants of the lower abdomen.
• The liver may be enlarged and tender.
• Vaginal examination reveals:
(1)Abnormal vaginal discharge which may be of purulent.
(2)Congested external urethral meatus or openings of Bartholin’s ducts through which
pus may be seen escaping out on pressure.
(3)Speculum examination shows congested cervix with purulent discharge from the
canal.
(4)Bimanual examination reveals bilateral tenderness on fornix palpation, which
increases more with movement of the cervix.
(5)There may be thickening, or a definite mass felt through the fornices.
17. Investigations
• Identification of organisms: For identification of organisms,
the materials are collected from the following available
sources:
1. Discharge from the urethra or Bartholin’s gland.
2. Cervical canal.
3. Collected pus from the fallopian tubes during laparoscopy or
laparotomy.
• The collected material is subjected to Gram stain and culture
(aerobic and anaerobic).
• Blood: Leucocyte count shows leucocytosis to more than
10,000 per cu mm and an elevated ESR value of more than
15 mm per hour. The results correlate with the severity of the
inflammatory reactions of the fallopian tubes as seen on
laparoscopy.
18. • Laparoscopy:Laparoscopic findings and severity of PID:
• Mild: Tubes: edema, erythema, no purulent exudates and mobile.
• Mod: Purulent exudates from the fimbrial ends, tubes not freely
movable.
• Severe: Pyosalpinx, inflammatory complex,abscess.
• ‘Violin string’ like adhesions in the pelvis and around the liver
suggests chlamydial infection.
• Sonography: Dilated and fluid-filled tubes, fluid in the pouch of
Douglas or adnexal mass are suggestive of PID.
21. Complications of PID
• Immediate: (1) Pelvic peritonitis or even generalized peritonitis.
(2) Septicemia—producing arthritis or myocarditis.
• Late:
(1) Dyspareunia.
(2) Infertility rate is 12 percent, after two episodes increase to 25 per cent and after three raises to 50
per cent. It is due to tubal damage or tubo-ovarian mass.
(3) Chronic pelvic inflammation is due to recurrent or associated pyogenic infection.
(4) Formation of adhesions or hydrosalpinx or pyosalpinx and tubo-ovarian abscess.
(5) Chronic pelvic pain and ill health.
(6) Increased risk of ectopic pregnancy (6-10 fold).
22. ROLE OF PHYSIOTHERAPY
• There is no role for physiotherapy in the acute phase of gynaecological infections.
• These must be promptly and properly diagnosed, and effectively treated with the correct
pharmacotherapy.
• However, in the chronic phase, where the organism is resistant to antibiotics or when adhesions are
causing pain, there may occasionally be a place for physiotherapeutic measures such as
continuous or pulsed short-wave diathermy.
• The women’s health physiotherapist can also offer coping strategies to deal with pain and stress,
and advice on the promotion of good health.
• Iontophoresis
• Salpingotomy
• Oophrectomy